KORU MEDICAL SYSTEMS, INC. Depreciation
KORU MEDICAL SYSTEMS, INC. (KRMD) reported Depreciation of $227.78 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-11-13
- KORU MEDICAL SYSTEMS, INC. depreciation for the quarter ending 2024-09-30 was $227.78K, a 13.96% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. depreciation for the quarter ending 2024-06-30 was $217.86K, a 2.32% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. depreciation for the quarter ending 2024-03-31 was $214.91K, a 8.96% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. depreciation for the quarter ending 2023-09-30 was $199.88K, a 34.48% increase year-over-year.
- KORU MEDICAL SYSTEMS, INC. depreciation for fiscal 2019 was $286.00K, a 4.59% increase from fiscal 2018.
- KORU MEDICAL SYSTEMS, INC. depreciation for fiscal 2018 was $273.45K.
- KORU MEDICAL SYSTEMS, INC. depreciation for fiscal 2017 was $267.85K, a 3.52% increase from fiscal 2016.
- KORU MEDICAL SYSTEMS, INC. depreciation for fiscal 2016 was $258.74K, a 3.73% decline from fiscal 2015.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 10 month | Depreciation 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $227.78K 10-Q · filed 2024-11-13 | $445.65K derived: sum of 2 quarters · filed 2024-11-13 | $677.02K 10-Q · filed 2024-11-13 | |||||
| 2024-06-30 | $217.86K 10-Q · filed 2024-08-07 | $449.23K 10-Q · filed 2024-08-07 | ||||||
| 2024-03-31 | $214.91K 10-Q · filed 2024-05-01 | |||||||
| 2023-09-30 | $199.88K 10-Q · filed 2024-11-13 | $412.80K derived: sum of 2 quarters · filed 2024-11-13 | $593.98K 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | $212.92K 10-Q · filed 2024-08-07 | $196.87K 10-Q · filed 2023-08-09 | $426.04K 10-Q · filed 2024-08-07 | $394.10K 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | $197.23K 10-Q · filed 2024-05-01 | |||||||
| 2022-09-30 | $148.63K 10-Q · filed 2023-11-08 | $130.88K 10-Q · filed 2022-11-09 | $259.11K derived: sum of 2 quarters · filed 2023-11-08 | $353.20K 10-Q · filed 2023-11-08 | $329.53K 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $110.48K 10-Q · filed 2023-08-09 | $104.56K 10-Q · filed 2022-08-03 | $204.56K 10-Q · filed 2023-08-09 | $198.64K 10-Q · filed 2022-08-03 | ||||
| 2022-03-31 | $94.08K 10-Q · filed 2023-05-04 | |||||||
| 2021-09-30 | $100.50K 10-Q · filed 2022-11-09 | $201.07K derived: sum of 2 quarters · filed 2022-11-09 | $301.47K 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $100.56K 10-Q · filed 2022-08-03 | $200.97K 10-Q · filed 2022-08-03 | ||||||
| 2021-03-31 | $100.40K 10-Q · filed 2022-05-04 | |||||||
| 2020-09-30 | $99.07K 10-Q · filed 2021-11-10 | $178.32K derived: sum of 2 quarters · filed 2021-11-10 | $251.08K 10-Q · filed 2021-11-10 | $318.76K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $79.25K 10-Q · filed 2021-08-11 | $152.01K 10-Q · filed 2021-08-11 | $219.69K derived: sum of 3 quarters · filed 2021-08-11 | $289.43K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $72.77K 10-Q · filed 2021-05-12 | $140.44K derived: sum of 2 quarters · filed 2021-05-12 | $210.18K derived: sum of 3 quarters · filed 2021-05-12 | $285.26K derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $67.68K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $137.42K derived: sum of 2 quarters · filed 2020-11-12 | $212.49K derived: sum of 3 quarters · filed 2020-11-12 | $286.00K 10-K · filed 2020-03-04 | ||||
| 2019-09-30 | $69.74K 10-Q · filed 2020-11-12 | $144.81K derived: sum of 2 quarters · filed 2020-11-12 | $218.33K 10-Q · filed 2020-11-12 | $288.80K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $75.07K 10-Q · filed 2020-08-05 | $148.59K 10-Q · filed 2020-08-05 | $219.06K derived: sum of 3 quarters · filed 2020-08-05 | $288.05K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $73.52K 10-Q · filed 2020-05-06 | $143.99K derived: sum of 2 quarters · filed 2020-05-06 | $212.98K derived: sum of 3 quarters · filed 2020-05-06 | $280.49K derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $70.47K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $139.47K derived: sum of 2 quarters · filed 2020-03-04 | $206.97K derived: sum of 3 quarters · filed 2020-03-04 | $273.45K 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | $68.99K 10-Q · filed 2019-11-06 | $136.50K derived: sum of 2 quarters · filed 2019-11-06 | $202.97K 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $67.50K 10-Q · filed 2019-08-07 | $133.98K 10-Q · filed 2019-08-07 | ||||||
| 2018-03-31 | $66.48K 10-Q · filed 2019-05-07 | |||||||
| 2017-12-31 | $233.63K 10-K · filed 2019-03-05 | |||||||
| 2017-09-30 | $70.90K 10-Q · filed 2018-11-09 | $141.05K derived: sum of 2 quarters · filed 2018-11-09 | $210.06K 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | $70.15K 10-Q · filed 2018-08-06 | $139.16K 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | $69.01K 10-Q · filed 2018-05-07 | |||||||
| 2017-02-28 | $267.85K 10-K · filed 2017-05-05 | |||||||
| 2016-02-29 | $258.74K 10-K · filed 2017-05-05 | |||||||
| 2015-02-28 | $268.76K 10-K · filed 2016-05-13 | |||||||
| 2014-02-28 | $225.61K 10-K · filed 2015-05-08 | |||||||
| 2013-02-28 | $186.52K 10-K · filed 2014-05-29 | |||||||
| 2012-02-29 | $98.66K 10-K · filed 2013-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |